scholarly journals Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds

2021 ◽  
Author(s):  
Sara Schukraft ◽  
Diego Arroyo ◽  
Mario Togni ◽  
Jean‐Jacques Goy ◽  
Peter Wenaweser ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Coronary Stents ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial

2018 ◽  
Vol 93 (1) ◽  
pp. E1-E7 ◽  
Author(s):  
J. Ribamar Costa ◽  
Alexandre Abizaid ◽  
Robert Whitbourn ◽  
Patrick W. Serruys ◽  
Nigel Jepson ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study

2017 ◽  
Vol 249 ◽  
pp. 119-126 ◽  
Author(s):  
Jiang Ming Fam ◽  
Cordula Felix ◽  
Yuki Ishibashi ◽  
Yoshinobu Onuma ◽  
Roberto Diletti ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Registry Study ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds

scholarly journals Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry

2018 ◽  
Vol 13 (13) ◽  
pp. 1554-1560 ◽  
Author(s):  
Andreas Baumbach ◽  
Azfar Zaman ◽  
Nick West ◽  
Peter O'Kane ◽  
Mohaned Egred ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds ◽  
One Year

Bioresorbable vascular scaffolds

2018 ◽  
pp. 569-582
Author(s):  
Adam J. Brown ◽  
Nick E. J. West
Keyword(s):  
Clinical Outcomes ◽  
Clinical Data ◽  
First Generation ◽  
Drug Eluting Stent ◽  
Interventional Techniques ◽  
Bioresorbable Scaffolds ◽  
Vascular Scaffolds ◽  
Drug Eluting ◽  
Bioresorbable Vascular Scaffolds

In this chapter, current limitations of existing metallic drug-eluting stent technology and potential advantages of bioresorbable scaffolds (BRSs) are explored, alongside existing clinical data for BRSs and interventional techniques that may optimize implantation of these novel first-generation devices, with consequent potential for improved clinical outcomes.

scholarly journals TCT-635 ACUTE AND MID-TERM CLINICAL OUTCOMES OF THE EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLDS IN AN ALL-COMER COHORT

2014 ◽  
Vol 64 (11) ◽  
pp. B185
Author(s):  
Ramez El Khoury ◽  
Charbel Naim ◽  
Nicolas Noiseux ◽  
Andre Kokis ◽  
François Gobeil ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Vascular Scaffolds ◽  
Bioresorbable Vascular Scaffolds
Sign in / Sign up

Export Citation Format

Share Document